Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Harris

Showing results (1081-1090 of 1,088) with videos related to

Pageof 109
Sort By:
You have reached the last page of results.This site can display upto 1,088 results.
Journal of Medicinal Chemistry|December 21, 2013
Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitorsAnthony A Estrada, Bryan K Chan, Charles Baker-Glenn, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acidsJavier de Vicente, Robert T Hendricks, David B Smith, et al.
Journal of Neuroengineering and Rehabilitation|November 8, 2017
How a diverse research ecosystem has generated new rehabilitation technologies: Review of NIDILRR's Rehabilitation Engineering Research CentersDavid J Reinkensmeyer, Sarah Blackstone, Cathy Bodine, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2024
Discovery of potent dihydro-oxazinoquinolinone inhibitors of GuaB for the treatment of tuberculosisYuebiao Zhou, Ignacio Aliagas, Shumei Wang, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinedionesJavier de Vicente, Robert T Hendricks, David B Smith, et al.
Journal of Medicinal Chemistry|September 19, 2012
Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitorsAnthony A Estrada, Xingrong Liu, Charles Baker-Glenn, et al.
Structure (London, England : 1993)|April 7, 2016
Outcome of the First wwPDB/CCDC/D3R Ligand Validation WorkshopPaul D Adams, Kathleen Aertgeerts, Cary Bauer, et al.
The New England Journal of Medicine|May 17, 2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular DiseaseW Schuyler Jones, Hillary Mulder, Lisa M Wruck, et al.
Pageof 109

Showing results (1081-1090 of 1,088) with videos related to

Sort By:
Pageof 109
You have reached the last page of results.This site can display upto 1,088 results.
Journal of Medicinal Chemistry|December 21, 2013
Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitorsAnthony A Estrada, Bryan K Chan, Charles Baker-Glenn, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acidsJavier de Vicente, Robert T Hendricks, David B Smith, et al.
Journal of Neuroengineering and Rehabilitation|November 8, 2017
How a diverse research ecosystem has generated new rehabilitation technologies: Review of NIDILRR's Rehabilitation Engineering Research CentersDavid J Reinkensmeyer, Sarah Blackstone, Cathy Bodine, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2024
Discovery of potent dihydro-oxazinoquinolinone inhibitors of GuaB for the treatment of tuberculosisYuebiao Zhou, Ignacio Aliagas, Shumei Wang, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinedionesJavier de Vicente, Robert T Hendricks, David B Smith, et al.
Journal of Medicinal Chemistry|September 19, 2012
Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitorsAnthony A Estrada, Xingrong Liu, Charles Baker-Glenn, et al.
Structure (London, England : 1993)|April 7, 2016
Outcome of the First wwPDB/CCDC/D3R Ligand Validation WorkshopPaul D Adams, Kathleen Aertgeerts, Cary Bauer, et al.
The New England Journal of Medicine|May 17, 2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular DiseaseW Schuyler Jones, Hillary Mulder, Lisa M Wruck, et al.
Pageof 109